Alumis (ALMS) Research & Development (2023 - 2026)
Alumis (ALMS) posted Research & Development of $85.34 million for Q2 2026, down 21.5% from $108.76 million a year earlier.
Powered by 
Analysis
Alumis (ALMS) Research & Development (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Alumis was $374.71 million, down 1.5% year-over-year; for FY2025, it was $386 million, up 45.4% from FY2024.
- In prior years, Alumis' Research & Development was $265.55 million in FY2024 (+92.9%) and $137.68 million in FY2023.
- Quarterly Research & Development has run from a low of $32.85 million in Q2 2023 to a high of $108.76 million in Q2 2025 over five years.
- On a year-over-year basis, Research & Development increased in five of the last seven quarters, with growth averaging 74.8%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2024, with growth of 152.0%; the weakest was Q2 2026, with a decline of 21.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Alumis | 891.03 Mn | -783.81 Mn | - | 85.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.34 Mn |
| Dec 31, 2025 | 82.79 Mn |
| Sep 30, 2025 | 97.84 Mn |
| Jun 30, 2025 | 108.76 Mn |
| Mar 31, 2025 | 96.62 Mn |
| Dec 31, 2024 | 87.20 Mn |
| Sep 30, 2024 | 87.82 Mn |
| Jun 30, 2024 | 48.57 Mn |
| Mar 31, 2024 | 41.96 Mn |
| Dec 31, 2023 | 34.61 Mn |
| Sep 30, 2023 | 37.79 Mn |
| Jun 30, 2023 | 32.85 Mn |
API Access
Alumis Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();